Year: 2019
Type: article
Abstract: With the improving survival of patients with myeloma, there is a need for the development of multiple different drug combinations for continued treatment and disease control. Reusing previously used drugs, especially as part of new combinations, is an attractive strategy.
Source: Cancer
DOI: 10.1002/cncr.32177
Author: Shaji K. Kumar
Institution: Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2944925719